| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Expected but not Quantified |
|---|
| Creation Date | 2012-09-11 17:31:23 UTC |
|---|
| Update Date | 2023-02-21 17:18:51 UTC |
|---|
| HMDB ID | HMDB0029598 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | Metenamine |
|---|
| Description | Metenamine, also known as hexamine or HMT, belongs to the class of organic compounds known as 1,3,5-triazinanes. These are triazinanes having three nitrogen ring atoms at the 1-, 3-, and 5- positions. Metenamine is a drug which is used for prophylactic or suppressive treatment of frequently recurring urinary tract infections when long-term therapy is considered necessary. this drug is not used to treat infection and should only be used after appropriate eradication of infection with antimicrobial agents. Based on a literature review a small amount of articles have been published on Metenamine. |
|---|
| Structure | InChI=1S/C6H12N4/c1-7-2-9-4-8(1)5-10(3-7)6-9/h1-6H2 |
|---|
| Synonyms | | Value | Source |
|---|
| 1,3,5,7-Tetraazatricyclo[3.3.1.1(3,7)]decane | ChEBI | | Hexamethylenamine | ChEBI | | Hexamethylene tetramine | ChEBI | | Hexamethylentetramin | ChEBI | | Hexamethylentetraminum | ChEBI | | Hexamine | ChEBI | | Hexaminum | ChEBI | | HMT | ChEBI | | HMTA | ChEBI | | Metenamina | ChEBI | | Methenamine | ChEBI | | Methenaminum | ChEBI | | Uritone | ChEBI | | Urotropin | ChEBI | | 1,3,5,7-Tetraazaadamantane | HMDB | | 1,3,5,7-Tetraazatricyclo (3.3.1.1(3,7))decane | HMDB | | 1,3,5,7-Tetraazatricyclo(3.3.1.13,7)decane | HMDB | | 1,3,5,7-Tetraazatricyclo(3.3.1.13,7)decane hydroiodide | HMDB | | 1,3,5,7-Tetraazatricyclo[3.3.1.13,7 ]decane | HMDB | | 1,3,5,7-Tetraazatricyclo[3.3.1.1~3,7~]decane | HMDB | | Aceto HMT | HMDB | | Aminoform | HMDB | | Aminoformaldehyde | HMDB | | Ammoform | HMDB | | Ammonioformaldehyde | HMDB | | Antihydral | HMDB | | Carin | HMDB | | Cystamin | HMDB | | Cystogen | HMDB | | Duirexol | HMDB | | e239 | HMDB | | Ekagom H | HMDB | | Esametilentetramina | HMDB | | Formaldehyde-ammonia 6:4 | HMDB | | Formamine | HMDB | | Formin | HMDB | | Formin (heterocycle) | HMDB | | Formin (the heterocyclic compound) | HMDB | | Grasselerator 102 | HMDB | | H.m.t. | HMDB | | Herax uts | HMDB | | Heterin | HMDB | | HEX | HMDB | | Hexa | HMDB | | Hexa (vulcanization accelerator) | HMDB | | Hexa-flo-pulver | HMDB | | Hexaform | HMDB | | Hexaloids | HMDB | | Hexamethylamine | HMDB | | Hexamethyleneamine | HMDB | | Hexamethylenetetraamine | HMDB | | Hexamethylenetetramine | HMDB | | Hexamethylenetetramine (aliphatic) | HMDB | | Hexamethylenetetramine, 8ci | HMDB | | Hexamethylenetetramine, acs | HMDB | | Hexamethylenetetramine-palladium chloride adduct | HMDB | | Hexamethylenetetraminum | HMDB | | Hexamethylentetramine | HMDB | | Hexamine (heterocycle) | HMDB | | Hexamine silver | HMDB | | Hexasan | HMDB | | Hexilmethylenamine | HMDB | | Mandelamine | HMDB | | Methamin | HMDB | | Methenamin | HMDB | | Methenamine silver | HMDB | | Metramine | HMDB | | Naphthamine | HMDB | | Natasol fast orange GR salt | HMDB | | Nocceler H | HMDB | | Preparation af | HMDB | | Resotropin | HMDB | | S 4 (Heterocycle) | HMDB | | Sanceler H | HMDB | | Silver methenamine | HMDB | | Tetraazaadamantane | HMDB | | Uramin | HMDB | | Uratrine | HMDB | | Urisol | HMDB | | Uro-phosphate | HMDB | | Urodeine | HMDB | | Urotropine | HMDB | | Vesaloin | HMDB | | Vesalvine | HMDB | | Vulkacit H 30 | HMDB | | Vulkacit H30 | HMDB | | Xametrin | HMDB | | [16]-Adamazane, inn | HMDB | | Methenamine, silver | HMDB | | Silver, hexamine | HMDB | | Silver, methenamine | HMDB |
|
|---|
| Chemical Formula | C6H12N4 |
|---|
| Average Molecular Weight | 140.1863 |
|---|
| Monoisotopic Molecular Weight | 140.106196404 |
|---|
| IUPAC Name | 1,3,5,7-tetraazatricyclo[3.3.1.1^{3,7}]decane |
|---|
| Traditional Name | 1,3,5,7-tetraazatricyclo[3.3.1.1^{3,7}]decane |
|---|
| CAS Registry Number | 100-97-0 |
|---|
| SMILES | C1N2CN3CN1CN(C2)C3 |
|---|
| InChI Identifier | InChI=1S/C6H12N4/c1-7-2-9-4-8(1)5-10(3-7)6-9/h1-6H2 |
|---|
| InChI Key | VKYKSIONXSXAKP-UHFFFAOYSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as 1,3,5-triazinanes. These are triazinanes having three nitrogen ring atoms at the 1-, 3-, and 5- positions. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organoheterocyclic compounds |
|---|
| Class | Triazinanes |
|---|
| Sub Class | 1,3,5-triazinanes |
|---|
| Direct Parent | 1,3,5-triazinanes |
|---|
| Alternative Parents | |
|---|
| Substituents | - 1,3,5-triazinane
- Azacycle
- Aminal
- Organic nitrogen compound
- Organopnictogen compound
- Hydrocarbon derivative
- Organonitrogen compound
- Aliphatic heteropolycyclic compound
|
|---|
| Molecular Framework | Aliphatic heteropolycyclic compounds |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Not Available |
|---|
| Role | |
|---|
| Physical Properties |
|---|
| State | Solid |
|---|
| Experimental Molecular Properties | |
|---|
| Experimental Chromatographic Properties | Experimental Collision Cross Sections |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 1.04 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 14.2392 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 5.06 minutes | 32390414 | | AjsUoB = Accucore 150 Amide HILIC with 10mM Ammonium Formate, 0.1% Formic Acid | 74.8 seconds | 40023050 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 2318.5 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 530.9 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 188.2 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 381.5 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 241.5 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 568.9 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 569.4 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 159.7 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 1113.8 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 406.0 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 1362.4 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 378.2 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 357.5 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 671.1 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 409.9 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 160.5 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatized |
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted GC-MS | Predicted GC-MS Spectrum - Metenamine GC-MS (Non-derivatized) - 70eV, Positive | splash10-0006-0900000000-37095c7b831e11e5eee2 | 2017-09-01 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Metenamine GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | | MS | Mass Spectrum (Electron Ionization) | splash10-0006-9300000000-e762ea01823717c4bda9 | 2014-09-20 | Not Available | View Spectrum |
MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Experimental LC-MS/MS | LC-MS/MS Spectrum - Metenamine LC-ESI-QQ , positive-QTOF | splash10-0006-0900000000-05c8e159897335060443 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Metenamine LC-ESI-QQ , positive-QTOF | splash10-01ox-2900000000-86fe33e31cc8f7108c14 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Metenamine LC-ESI-QQ , positive-QTOF | splash10-01ti-9300000000-7eb44254c8cc65c09acd | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Metenamine LC-ESI-QQ , positive-QTOF | splash10-004i-9000000000-fd4edf8f48f9c42bca0c | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Metenamine LC-ESI-QQ , positive-QTOF | splash10-004l-9000000000-371b89c99afba4931848 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Metenamine 10V, Positive-QTOF | splash10-0006-0900000000-fdd6b719cb07e4102442 | 2016-08-02 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Metenamine 20V, Positive-QTOF | splash10-0006-0900000000-fdd6b719cb07e4102442 | 2016-08-02 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Metenamine 40V, Positive-QTOF | splash10-0006-0900000000-fdd6b719cb07e4102442 | 2016-08-02 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Metenamine 10V, Negative-QTOF | splash10-000i-0900000000-4c20ce3a6256ce9cf869 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Metenamine 20V, Negative-QTOF | splash10-000i-0900000000-4c20ce3a6256ce9cf869 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Metenamine 40V, Negative-QTOF | splash10-000i-0900000000-4c20ce3a6256ce9cf869 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Metenamine 10V, Negative-QTOF | splash10-000i-0900000000-df90583457c277060500 | 2021-09-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Metenamine 20V, Negative-QTOF | splash10-000i-0900000000-df90583457c277060500 | 2021-09-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Metenamine 40V, Negative-QTOF | splash10-000i-0900000000-df90583457c277060500 | 2021-09-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Metenamine 10V, Positive-QTOF | splash10-0006-0900000000-96b1ccc7b2dbac963a64 | 2021-09-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Metenamine 20V, Positive-QTOF | splash10-0006-0900000000-96b1ccc7b2dbac963a64 | 2021-09-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Metenamine 40V, Positive-QTOF | splash10-0006-0900000000-96b1ccc7b2dbac963a64 | 2021-09-22 | Wishart Lab | View Spectrum |
NMR Spectra| Spectrum Type | Description | Deposition Date | Source | View |
|---|
| Predicted 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum |
IR Spectra| Spectrum Type | Description | Deposition Date | Source | View |
|---|
| Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M+H]+) | 2023-02-03 | FELIX lab | View Spectrum | | Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M+Na]+) | 2023-02-03 | FELIX lab | View Spectrum |
|
|---|